Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers

J Affect Disord. 2020 Feb 15:263:353-366. doi: 10.1016/j.jad.2019.11.108. Epub 2019 Nov 23.

Abstract

Background: Reverse translating putative biomarkers of depression from patients to animals is complex because Major Depressive Disorder (MDD) is a highly heterogenous condition. This review proposes an approach to reverse translation based on relating relevant bio-behavioural functions in laboratory rodents to MDD symptoms.

Methods: This systematic review outlines symptom clusters assessed by psychometric tests of MDD and antidepressant treatment response including the Montgomery-Åsberg Depression Rating Scale, the Hamilton Depression Rating Scale, and the Beck Depression Inventory. Symptoms were related to relevant behavioural assays in laboratory rodents.

Results: The resulting battery of tests includes passive coping, anxiety-like behaviours, sleep, caloric intake, cognition, psychomotor functions, hedonic reactivity and aversive learning. These assays are discussed alongside relevant clinical symptoms of MDD, providing a framework through which reverse translation of a biomarker can be interpreted.

Limitations: Certain aspects of MDD may not be quantified by tests in laboratory rodents, and their biological significance may not always be of clinical relevance.

Conclusions: Using this reverse translation approach, it is possible to clarify the functional significance of a putative biomarker in rodents and hence translate its contribution to specific clinical symptoms, or clusters of symptoms.

Keywords: Antidepressant drug treatment response; Beck Depression inventory; Hamilton rating scale for depression; Major depressive disorder; Montgomery–Åsberg depression rating scale; Reverse translation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Animals
  • Antidepressive Agents / therapeutic use
  • Anxiety Disorders / drug therapy
  • Biomarkers*
  • Depressive Disorder, Major* / diagnosis
  • Depressive Disorder, Major* / drug therapy
  • Humans
  • Phenotype
  • Psychiatric Status Rating Scales

Substances

  • Antidepressive Agents
  • Biomarkers